Equities

Binovi Technologies Corp

VISN.H:NEX

Binovi Technologies Corp

Actions
  • Price (CAD)0.085
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 07 2022.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Binovi Technologies Corp. is a Canada-based company, which provides software-based solution. The Company is focused on the development and commercialization of visual and neuro-cognitive processing products and manufactures hardware and software for diagnosing and remediating visual perception disorders. The Company’s platform, Binovi Connect, is used across the globe by a multitude of users, including optometrists, sports organizations and for educational purposes. Binovi Connect is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance. The Binovi Connect App is a software-as-a-service-based solution, which provides one-on-one cognitive training and learning protocols for K-12 Students, Vision Care Specialists, and Sports Performance testing and training.

  • Revenue in CAD (TTM)--
  • Net income in CAD--
  • Incorporated2011
  • Employees0.00
  • Location
    Binovi Technologies CorpSuite 1500, 1055 West Georgia StreetVANCOUVER V6E 4N7CanadaCAN
  • Phone+1 (647) 289-6640
  • Fax+1 (416) 943-6271
  • Websitehttps://binovi.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ZoomMed Inc154.28k1.46m2.10m------1.3613.610.01070.01070.0011-0.001415.76--46.89--14,863.23----------943.16----------3,951.93--114.30------
Yangaroo Inc10.71m254.89k2.19m17.008.360.37181.470.20410.00420.00420.17190.09410.9491--5.38--2.2610.203.5513.74----2.387.58--1.570.41440.00-0.00765.573,408.0592.4360.99--
Binovi Technologies Corp-100.00bn-100.00bn2.25m0.00---------------0.0873-----------170.25---254.88--71.98---1,712.660.3215-------74.4213.94-79.12------
Pluribus Technologies Corp37.61m-5.50m2.39m----0.0594--0.0637-0.3471-0.34712.372.520.40852,122.466.97---5.98---8.59--63.31---14.63--0.1742-0.41620.3718--105.42--58.05------
Katipult Technology Corp2.50m-1.77m2.50m--------1.00-0.0247-0.02470.0349-0.0721.93--8.22---136.69-87.48---219.7782.5980.16-70.70-86.87---0.797326.37--34.0115.32-9.83------
Kovo Healthtech Corp13.37m-3.96m2.59m----1.34--0.1937-0.079-0.0790.27950.03371.18--49.72---34.86---59.05-------29.59-----3.370.8112--78.62--90.74------
Ginsms Inc3.19m-128.57k2.81m--------0.8803-0.0007-0.00070.017-0.01313.19--5.35---12.96-4.16----41.3036.51-4.07-1.39---1.31----5.44-9.85-306.22--12.40--
Data as of Jul 07 2022. Currency figures normalised to Binovi Technologies Corp's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.